Publication

Article

Cardiology Review® Online

December 2006
Volume23
Issue 12

A patient with ST-segment elevation myocardial infarction and normal left ventricular function

A 55-year-old man with a history of hypercholesterolemia presented to the emergency department with severe crushing chest pain radiating to the left arm for a duration of 1 hour.

A 55-year-old man with a history of hypercholesterolemia presented to the emergency department with severe crushing chest pain radiating to the left arm for a duration of 1 hour. An electrocardiogram showed ST-segment elevation in the inferior leads.

The patient underwent emergency primary angioplasty with good angiographic results. The ST-segment elevation and symptoms resolved. An echocardiogram the next morning showed normal left ventricular function, with an estimated ejection fraction of 55% and mild inferior hypokinesis.

The patient was discharged with instructions to take aspirin, clopidogrel (Plavix), metoprolol (Lopressor, Toprol XL), and an HMG-CoA reductase inhibitor. Should this patient be receiving an angiotensin-converting enzyme inhibitor? What is the evidence supporting this decision?

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.